Oriola
Espoo · Founded 2006
About Oriola
Oriola-KD has a solid position in consumer and services business in the pharmaceutical markets in Sweden, Finland and Baltic countries. Oriola-KD offers expert advice on health and wellbeing and an extensive and high-quality selection of products in its own pharmacies. To healthcare operators, Oriola-KD provides wide service offering covering pharmaceutical distribution, branded products and other tailored services. Oriola-KD unites consumers and pharmaceutical companies in a unique way. Oriola-KD provides pharmaceutical companies an effective access to markets and improves consumers' wellbeing by ensuring that pharmaceuticals, health products and services are delivered in a safe and customer-friendly manner. Oriola-KD’s net sales for continuing operations in 2015 were approximately EUR 1.6 billion.
Company Facts
- Founded: 2006
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $1M – $10M
- Total funding: $80.3M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jun 2025)
- Ticker: fra:O5O
- Website: oriola.com
- Phone: 358 10 429 99
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/oriola-29693 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.